SCHEMBL7474554

SCHEMBL7474554

CC(=NNc1cccc(C#N)c1)OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 1/20 0.44
GPR17 Q13304 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
IDO1 P14902 1/20 0.41
ALDH1A1 P00352 4/20 0.41
GAA P10253 1/20 0.41
F9 P00740 1/20 0.38
KCNJ6 P48051 1/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38
SLC2A1 P11166 1/20 0.38
KDM4E B2RXH2 2/20 0.37
PDE4B Q07343 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
GPR119 Q8TDV5 1/20 0.37
ATIC P31939 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568797 0.86 P2RY2 (0.42) P2RY2GPR17SMN1; SMN2POLBIDO1
SCHEMBL7637263 0.86 P2RY2 (0.42) P2RY2GPR17SMN1; SMN2POLBIDO1
SCHEMBL7562044 0.84 SMN1; SMN2 (0.43) P2RY2GPR17SMN1; SMN2POLBIDO1
SCHEMBL22095296 0.73 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1GAAMEN1MAPT
SCHEMBL22095297 0.73 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1GAAMEN1MAPT
SCHEMBL23928549 0.73 MAPT (0.49) SMN1; SMN2ALDH1A1GAAPDE4BMEN1
SCHEMBL7568763 0.71 PDK1 (0.45) SMN1; SMN2POLBALDH1A1KCNJ6KCNJ5
SCHEMBL7571560 0.71 PDK1 (0.45) SMN1; SMN2POLBALDH1A1KCNJ6KCNJ5
SCHEMBL17287764 0.70 GPR17 (0.64) P2RY2GPR17ALDH1A1GAAMEN1
SCHEMBL27602928 0.69 BCHE (0.47) P2RY2GPR17SMN1; SMN2IDO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222172-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE Bristol-Myers Squibb Pharma Company (US) 2002-07-17 EP disclosed
WO-2001029006-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-04-26 WO disclosed